GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Holy Stone Healthcare Co Ltd (ROCO:4194) » Definitions » Median PS Value

Holy Stone Healthcare Co (ROCO:4194) Median PS Value : NT$18.60 (As of Dec. 16, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Holy Stone Healthcare Co Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. Holy Stone Healthcare Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was NT$1.962. Holy Stone Healthcare Co's 10-Year median PS Ratio is 9.4801. Therefore, the Median PS Value for today is NT$18.60.

As of today (2024-12-16), Holy Stone Healthcare Co's share price is NT$13.05. Holy Stone Healthcare Co's Median PS Value is NT$18.60. Therefore, Holy Stone Healthcare Co's Price to Median PS Value for today is 0.70.

The historical rank and industry rank for Holy Stone Healthcare Co's Median PS Value or its related term are showing as below:

ROCO:4194' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.7   Med: 1.01   Max: 1.01
Current: 0.7

During the past 11 years, the highest Price to Median PS Value of Holy Stone Healthcare Co was 1.01. The lowest was 0.70. And the median was 1.01.

ROCO:4194's Price-to-Median-PS-Value is ranked better than
50.38% of 264 companies
in the Biotechnology industry
Industry Median: 0.7 vs ROCO:4194: 0.70

Holy Stone Healthcare Co Median PS Value Historical Data

The historical data trend for Holy Stone Healthcare Co's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Holy Stone Healthcare Co Median PS Value Chart

Holy Stone Healthcare Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 18.60

Holy Stone Healthcare Co Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 18.60 -

Competitive Comparison of Holy Stone Healthcare Co's Median PS Value

For the Biotechnology subindustry, Holy Stone Healthcare Co's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Holy Stone Healthcare Co's Price-to-Median-PS-Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Holy Stone Healthcare Co's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where Holy Stone Healthcare Co's Price-to-Median-PS-Value falls into.



Holy Stone Healthcare Co Median PS Value Calculation

Holy Stone Healthcare Co's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=1.962*9.4801
=18.60

10-Year Median PS Ratio is 9.4801.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Holy Stone Healthcare Co's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2024 was NT$1.962.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Holy Stone Healthcare Co  (ROCO:4194) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

Holy Stone Healthcare Co's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=13.05/18.60
=0.70

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Holy Stone Healthcare Co Median PS Value Related Terms

Thank you for viewing the detailed overview of Holy Stone Healthcare Co's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


Holy Stone Healthcare Co Business Description

Traded in Other Exchanges
N/A
Address
Number 88, Section 1, Neihu Road, 4th Floor, Neihu District, Taipei, TWN, 11493
Holy Stone Healthcare Co Ltd is a Taiwan based company focused on a biopolymer drug delivery platform. It is involved in the development of new drugs and medical devices, especially hyaluronic acid related therapeutic products. The products of the company include RenehaVis, SportVis, TRUD, and GAF.

Holy Stone Healthcare Co Headlines

No Headlines